3rd Annual MedAffairs

3rd Annual MedAffairs Leaders Forum USA

The most competitive pharma companies in the coming decade will be masters of data and digital technologies. Anju has a comprehensive understanding of the unique requirements of Medical Information departments enabling us to deliver world class software solutions, cost effectively. Our medical information software has been established as the global industry standard.

Anju Software is a proud sponsor of the 3rd Annual MedAffairs Leaders Forum. Reed McLaughlin, Vice President of Sales is representing Anju’s Medical Affairs Division on the floor, booth# 2. He would be happy to chat with you about all medical information needs for your organization. Stop by to check out how we can help you manage your data.

About MedAffairs Leaders Forum

The MedAffairs Leaders Forum is widely-recognized as the place where medical affairs professionals obtain actionable insights to transform medical affairs into a function that truly adds-value to healthcare systems and especially patients. Attendees will network with experts and thought-leaders to understand issues like:

  • Patient-centricity: How to change culture, add-value and put the patient at the center of the organization in practice
  • Digital: Realizing the potential and the power that technology provides, whether it’s tapping unique external data sources, understanding patient needs through online patient communities, or enhancing R&D intelligence through Artificial Intelligence or Big Data.
  • Communications: Leveraging both classical communications channels, such as publications or symposia, as well as social media, to ethically communicate evidence-based messages with key stakeholders.
  • Real-world evidence and IITs: Working with External Experts, academic networks, registries or payers to achieve a more granular-level understanding of how a therapy works in the real world.

Check the meeting details here

If you would like to join us at the conference, register here.

Want to stay up to date with our news?

To top